Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2226 - 2250 of 2342 in total
Sub Class LM ID Name ▼ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC06
  • Forssman antigen(d18:1/26:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260185 1569.985817 C78H143N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC07
  • Forssman antigen(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260186 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC05
  • Forssman antigen(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260184 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC04
  • Forssman antigen(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260183 1513.923217 C74H135N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC03
  • Forssman antigen(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260182 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC00
  • Forssman antigen
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1161 18056
Simple Glc series LMSP05010156
  • Flavuside B
  • N-(2R-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
753.575484 C43H79NO9
Simple Glc series LMSP05010155
  • Flavuside A
  • N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
755.591134 C43H81NO9
Simple Glc series LMSP05010117
  • Flavicerebroside B
  • N-(2R-hydroxy-3E-octadecenoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E-dienine
21778037 753.575484 C43H79NO9
Simple Glc series LMSP05010116
  • Flavicerebroside A
  • N-(2R-hydroxy-octadecanoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E-dienine
21778036 755.591134 C43H81NO9
Simple Glc series LMSP05010037
  • FMC-6(d18:1/24:0(2-OH))
  • N-(2-hydroxy-tetracosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931248 1037.737859 C58H103NO14
Simple Glc series LMSP05010038
  • FMC-6(d18:1/22:0(2-OH))
  • N-(2-hydroxy-docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931249 1009.706559 C56H99NO14
Simple Glc series LMSP05010036
  • FMC-5(d18:1/24:1)
  • N-(15Z-tetracosenoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931247 1019.727294 C58H101NO13
Simple Glc series LMSP05010035
  • FMC-5(d18:1/24:0)
  • N-(tetracosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931246 1021.742944 C58H103NO13
Simple Glc series LMSP05010034
  • FMC-5(d18:1/22:0)
  • N-(docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
132274113 136366 993.711644 C56H99NO13
Simple Glc series LMSP05010033
  • FMC-5(d18:1/20:0)
  • N-(eicosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931244 965.680344 C54H95NO13
Simple Glc series LMSP05010032
  • FMC-5(d18:1/18:0)
  • N-(octadecanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
52931243 937.649044 C52H91NO13
Simple Glc series LMSP05010041
  • Dracontioside B
  • N-(2R-hydroxytetracosanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine
9832502 843.679949 C48H93NO10
Simple Glc series LMSP05010040
  • Dracontioside A
  • N-(2R-hydroxyoctadecanoyl)-1-beta-glucosyl-4E,8Z-octadecasphingadienine
134812535 741.575484 C42H79NO9
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR08
  • Cytolipin R(d18:1/26:1(17Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261579 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR06
  • Cytolipin R(d18:1/26:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261577 1366.906443 C70H130N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR07
  • Cytolipin R(d18:1/24:1(15Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261578 1336.859493 C68H124N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR05
  • Cytolipin R(d18:1/24:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261576 1338.875143 C68H126N2O23

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024